ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 95382 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 95382; 2) Community: the network communities that were significantly associated with the response to NSC 95382; 3) Molecule: the relationships between components within communities and NSC 95382; 4) MDR: the compounds that were significantly associated with the NSC 95382.

NSC Compound Enrichment Correlation
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0114553853234977 0.3881066
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0114553853234977 0.44555807
NSC 603071 Aminocamptothecin 0.0114553853234977 0.78057641
NSC 606499 Camptothecin Derivative 0.0114553853234977 0.77311504
NSC 615534 Null 0.0114553853234977 0.084918955
NSC 673652 2-Ethylaminoestradiol 0.0114553853234977 0.23958184
NSC 674182 Null 0.0114553853234977 0.63737712
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0114553853234977 0.037037438
NSC 681632 Camptothecin Derivative 0.0114553853234977 0.78445524
NSC 681633 Camptothecin Derivative 0.0114553853234977 0.81757988
Total:69  Current:18    [First] [Prev] [Next] [Last]